Inve India ▾
ACACI

Archean Chemical Industries Q3 FY26 results (Oct–Dec 2025) and concall

Chemicals · Concall AI · Call held 6 Feb 2026

Archean Chemical reported mixed results for Q3 FY26, with standalone revenue growing 2.4% YoY to INR 2,608.1 million, but EBITDA declining 27% YoY to INR 698.6 million due to operational challenges and cost pressures. While industrial salt and elemental bromine showed strong demand, bromine derivatives faced margin compression, and the SOP project continued to experience delays. The company is actively progressing its strategic initiatives in semiconductors and energy storage.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

What they filed

Q3 FY26: revenue up 2.9%, net profit down 39.3% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Revenue238 243 322 279 221 −7%250 +3%
EBITDA76 84 90 83 65 −14%59 −30%
Net profit22 56 58 52 38 +73%34 −39%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.